EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 16-Jun-2025 01:09 ET (16-Jun-2025 05:09 GMT/UTC)

HPV drives tumor development in rare nasal cancers

Johns Hopkins Medicine
Peer-Reviewed Publication

Human papillomavirus (HPV) can drive tumor development in some rare sinonasal squamous cell carcinomas (SNSCCs), according to a new comprehensive study of these tumors from investigators at the Johns Hopkins University School of Medicine and the Johns Hopkins Kimmel Cancer Center. The researchers also identified common mutations among these cancers and a potential combination treatment during the study, which was partially supported by the National Institutes of Health.

Journal: Nature Communications
Funder: Center for Cancer Research, NIH/National Cancer Institute, Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC

CCNE1 promotes the progression of hepatic precancerous lesion and the malignant phenotype of hepatocellular carcinoma

Xia & He Publishing Inc.
Peer-Reviewed Publication

The diagnosis of hepatic precancerous lesions (HPC) and early hepatocellular carcinoma (HCC) has significant public health implications and holds the potential to reduce the global burden of HCC. This study aimed to identify molecular features and biomarkers associated with HPC progression and early HCC development.

Journal: Journal of Clinical and Translational Hepatology

Rare non-small cell lung cancer with brain metastases responds to amivantamab monotherapy

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – June 11, 2025 – A new research paper was published in Volume 16 of Oncotarget on May 29, 2025, titled “Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib.”

Journal: Oncotarget

FTO promotes hepatocellular carcinoma progression by mediating m6A modification of BUB1 and targeting TGF-βR1 to activate the TGF-β signaling pathway

Xia & He Publishing Inc.
Peer-Reviewed Publication

Fat mass and obesity-associated protein (FTO) has been linked to various cancers, though its role in hepatocellular carcinoma (HCC) remains unclear. This study aimed to investigate FTO expression, its clinical relevance, functional role in HCC progression, and the underlying molecular mechanisms.

Journal: Journal of Clinical and Translational Hepatology

New JNCCN study showcases how telehealth helps overcome geographic and resource gaps in cancer care globally

National Comprehensive Cancer Network
Peer-Reviewed Publication

New research in JNCCN found that older people with cancer had better daily functioning, improved mood, stronger illness understanding, and a higher quality of life if they participated in a telehealth-based care program.

Journal: Journal of the National Comprehensive Cancer Network

Program helps cancer survivors return to work with confidence

McGill University
Peer-Reviewed Publication

A new pilot project led by McGill University researchers is showing early success in helping cancer survivors return to work, addressing an aspect of recovery they say is often overlooked.

iCanWork is an online support program being developed by Christine Maheu, Associate Professor at McGill’s Ingram School of Nursing, in collaboration with BC Cancer.

Journal: Current Oncology

Chinese Medical Journal article decodes the role of neurotransmitter receptors in cancer progression

Chinese Medical Journals Publishing House Co., Ltd.
Peer-Reviewed Publication

As cancer neuroscience continues to evolve, this review delves into the pivotal role of neurotransmitter receptors at the intersection of neurobiology and tumor biology. By analyzing involvement in key signaling pathways such as β-adrenergic and GABAergic, the study uncovers how these receptors drive cancer progression, modulate immune responses, and contribute to therapy resistance. Highlighting emerging NR-targeted therapies, the review sets the stage for more personalized, precision-based cancer treatments and marks a promising direction for future research.

Journal: Chinese Medical Journal

First ever ESC Cardio-Oncology Conference to take place in Florence, Italy: Heart-related side effects of cancer treatment demand urgent attention

European Society of Cardiology
Meeting Announcement

1 in 3 cancer patients may experience serious cardiovascular side effects from treatment. The European Society of Cardiology (ESC), through its Council of Cardio-Oncology is launching a dedicated conference to focus on the growing epidemic. Taking place on 20 and 21 June in Florence, Italy, the conference will emphasise multidisciplinary collaboration. Highlights include joint sessions with related organisations, as well as interactive workshops, and case-based sessions.

Pancreatic cancer vaccines eliminate disease in preclinical studies

Case Western Reserve University
Grant and Award Announcement

Researchers at Case Western Reserve University and Cleveland Clinic are developing vaccines targeting pancreatic cancer that could eliminate the disease, leaving a patient cancer-free. So far, the vaccines have achieved dramatic results in studies with preclinical models.

Funder: NIH/National Cancer Institute

The glucocorticoid receptor is a double-edged sword in prostate cancer

University of Eastern Finland
Peer-Reviewed Publication

A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor can both promote and inhibit prostate cancer progression, depending on the circumstances.

Journal: Genome Research

2
3
4
5
6